Avoiding the data swamp: The transformative power of AI
Our Co-founder and CEO discusses the evolving role of the cloud and AI-powered tools in drug development.
Podcasts
How to launch and scale a disruptive startup in an industry that values stability.
Our co-founder, Nathan Clark, sat down with The Scale Up Show's Ryan Staley at the end of last year for a conversation on entrepreneurship and the future of software and AI in biotech that's suddenly very timely. The broad rollout of generative AI tools like ChatGPT
How is the cloud transforming lab operations, from R&D to manufacturing?
Our co-founder, Nathan Clark, recently joined IoT One's Erik Walenza on their Industrial IoT Spotlight podcast for a cross-continental conversation on the challenges of integrating early stage R&D lab operations (focused on finding therapeutics) with later stage manufacturing (focused on actually making them). Learn how you
Our co-founder Nathan Clark discusses modern labs on Qualio's From Lab to Launch podcast.
Today's life sciences labs are over-saturated with data, even at the earliest stage biotechs. This creates severe industry-wide inefficiencies and compliance conundrums. On a human level, the inability to deal with all of this data needlessly limits the impact of each person working at every life sciences company.